Overcoming the Refractory Expression of Secreted Recombinant Proteins in Mammalian Cells through Modification of the Signal Peptide and Adjacent Amino Acids | PLOS ONE
Frontiers | Phage Display Derived Monoclonal Antibodies: From Bench to Bedside
Expressing anti-HIV VRC01 antibody using the murine IgG1 secretion signal in Pichia pastoris | AMB Express | Full Text
The SARS-CoV-2 Spike protein has a broad tropism for mammalian ACE2 proteins | PLOS Biology
Broad immunity to SARS-CoV-2 variants of concern mediated by a SARS-CoV-2 receptor-binding domain protein vaccine - eBioMedicine
Anti-Human Kappa FITC/Lambda PE
IMGT®, the international ImMunoGeneTics information system®
Validation of the Interagency Integrated Triage Tool in a resource-limited, urban emergency department in Papua New Guinea: a pilot study - The Lancet Regional Health – Western Pacific
NHS-dPEG®₄-biotin - Quanta BioDesign
Frontiers | Proteome and Microbiome Mapping of Human Gingival Tissue in Health and Disease
Biology | Free Full-Text | Targets of Immune Escape Mechanisms in Cancer: Basis for Development and Evolution of Cancer Immune Checkpoint Inhibitors
Summary of the signal peptides used in this study. | Download Table
Poster Abstracts - 2023 - Asia-Pacific Journal of Clinical Oncology - Wiley Online Library
Overcoming the Refractory Expression of Secreted Recombinant Proteins in Mammalian Cells through Modification of the Signal Peptide and Adjacent Amino Acids | PLOS ONE
The SARS-CoV-2 Spike protein has a broad tropism for mammalian ACE2 proteins | PLOS Biology
Frontiers | Bovine Immunology: Implications for Dairy Cattle
Frontiers | NF-κB: At the Borders of Autoimmunity and Inflammation
Overcoming the Refractory Expression of Secreted Recombinant Proteins in Mammalian Cells through Modification of the Signal Peptide and Adjacent Amino Acids | PLOS ONE
Quelques définitions | FFRMG
Broad immunity to SARS-CoV-2 variants of concern mediated by a SARS-CoV-2 receptor-binding domain protein vaccine - eBioMedicine
Frontiers | Phage Display Derived Monoclonal Antibodies: From Bench to Bedside
